COMPANIES In a world where large pharmaceutical companies worry about their empty pipelines, and small biotechnology groups survive only if new products pass clinical trials, it sometimes seems that the only way to succeed in the medicines business is by creating new drugs.
But a small cluster of British drug companies is quietly making the opposite bet: by marketing drugs that are decades old, relying on consumers’ affection for products that they probably first saw in their grandparents’ medicine chest.
